| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Ispinesib Mesylate | GDSC1000 | pan-cancer | AAC | -0.19 | 3e-09 |
| mRNA | Vinorelbine | GDSC1000 | pan-cancer | AAC | -0.19 | 1e-07 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.27 | 6e-07 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | -0.16 | 3e-06 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | -0.14 | 3e-06 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | -0.15 | 4e-06 |
| mRNA | JNK-9L | GDSC1000 | pan-cancer | AAC | -0.16 | 6e-06 |
| mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | -0.16 | 8e-06 |
| mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | -0.17 | 1e-05 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.14 | 1e-05 |